1. Home
  2. GNFT vs SES Comparison

GNFT vs SES Comparison

Compare GNFT & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • SES
  • Stock Information
  • Founded
  • GNFT 1999
  • SES 2012
  • Country
  • GNFT France
  • SES United States
  • Employees
  • GNFT N/A
  • SES N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • SES Auto Parts:O.E.M.
  • Sector
  • GNFT Health Care
  • SES Consumer Discretionary
  • Exchange
  • GNFT Nasdaq
  • SES Nasdaq
  • Market Cap
  • GNFT 296.4M
  • SES 355.0M
  • IPO Year
  • GNFT 2019
  • SES N/A
  • Fundamental
  • Price
  • GNFT $4.50
  • SES $0.27
  • Analyst Decision
  • GNFT Strong Buy
  • SES Sell
  • Analyst Count
  • GNFT 1
  • SES 2
  • Target Price
  • GNFT $13.00
  • SES $1.25
  • AVG Volume (30 Days)
  • GNFT 6.3K
  • SES 3.6M
  • Earning Date
  • GNFT 09-19-2024
  • SES 10-31-2024
  • Dividend Yield
  • GNFT N/A
  • SES N/A
  • EPS Growth
  • GNFT N/A
  • SES N/A
  • EPS
  • GNFT 0.47
  • SES N/A
  • Revenue
  • GNFT $86,225,222.00
  • SES N/A
  • Revenue This Year
  • GNFT $155.44
  • SES N/A
  • Revenue Next Year
  • GNFT N/A
  • SES N/A
  • P/E Ratio
  • GNFT $9.31
  • SES N/A
  • Revenue Growth
  • GNFT 175.45
  • SES N/A
  • 52 Week Low
  • GNFT $3.08
  • SES $0.20
  • 52 Week High
  • GNFT $6.42
  • SES $2.57
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 28.81
  • SES 20.72
  • Support Level
  • GNFT $5.10
  • SES $0.27
  • Resistance Level
  • GNFT $5.81
  • SES $0.73
  • Average True Range (ATR)
  • GNFT 0.21
  • SES 0.05
  • MACD
  • GNFT -0.16
  • SES -0.01
  • Stochastic Oscillator
  • GNFT 6.13
  • SES 17.50

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About SES SES AI Corporation

SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.

Share on Social Networks: